IE41024B1 - Process for obtaining antigens from schistosomes, agent containing these antigens and its use - Google Patents

Process for obtaining antigens from schistosomes, agent containing these antigens and its use

Info

Publication number
IE41024B1
IE41024B1 IE940/75A IE94075A IE41024B1 IE 41024 B1 IE41024 B1 IE 41024B1 IE 940/75 A IE940/75 A IE 940/75A IE 94075 A IE94075 A IE 94075A IE 41024 B1 IE41024 B1 IE 41024B1
Authority
IE
Ireland
Prior art keywords
antigens
schistosomes
agent containing
obtaining
way
Prior art date
Application number
IE940/75A
Other versions
IE41024L (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IE41024L publication Critical patent/IE41024L/en
Publication of IE41024B1 publication Critical patent/IE41024B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Schistosomes obtained by perfusion from blood of infected animals are kept alive for several hours in a sterile physiologically tolerated aqueous saline solution which is free of protein and essentially of nitrogen. In this way a large proportion of host-specific material is removed from them. The schistosomes purified in this way provide somatic antigens of increased specificity for detecting bilharzia in vitro. [GB1478082A]
IE940/75A 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use IE41024B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (en) 1974-04-29 1974-04-29 Process for preparing specific antigens from schistosomes and agent containing them

Publications (2)

Publication Number Publication Date
IE41024L IE41024L (en) 1975-10-29
IE41024B1 true IE41024B1 (en) 1979-10-10

Family

ID=5914244

Family Applications (1)

Application Number Title Priority Date Filing Date
IE940/75A IE41024B1 (en) 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use

Country Status (16)

Country Link
JP (1) JPS50145518A (en)
AT (1) AT344329B (en)
BE (1) BE828565A (en)
CA (1) CA1052694A (en)
CH (1) CH617775A5 (en)
DE (1) DE2420706C3 (en)
DK (1) DK140044C (en)
EG (1) EG12734A (en)
ES (1) ES436866A1 (en)
FR (1) FR2268532B1 (en)
GB (1) GB1478082A (en)
IE (1) IE41024B1 (en)
IT (1) IT1049537B (en)
LU (1) LU72375A1 (en)
NL (1) NL7504853A (en)
ZA (1) ZA752717B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356428A1 (en) * 1976-06-29 1978-01-27 Inserm Ctre Technologie Biomed PROCESS FOR PREPARATION OF AN IMMUNOLOGICAL ANTIPARASITIC AGENT, PRODUCT OBTAINED AND ITS APPLICATION
FR2601037B1 (en) * 1986-07-03 1988-10-21 Pasteur Institut PEPTIDE HAVING ISOLATED ANTIGENIC PROPERTIES OF PROTEIN 28 KD FROM S. MANSONI AND ITS ISOLATION METHOD, MONOCLONAL ANTIBODIES RECOGNIZING AT LEAST ONE EPITOPE OF SAID PEPTIDE AND APPLICATION OF SAME IN THE INDUCTION OF ANTIBODY SYNTHESIS

Also Published As

Publication number Publication date
DE2420706C3 (en) 1979-11-22
FR2268532B1 (en) 1980-01-25
DK184575A (en) 1975-10-30
CA1052694A (en) 1979-04-17
FR2268532A1 (en) 1975-11-21
CH617775A5 (en) 1980-06-13
IT1049537B (en) 1981-02-10
BE828565A (en) 1975-10-29
DK140044B (en) 1979-06-11
DK140044C (en) 1979-11-12
DE2420706B2 (en) 1979-03-22
AT344329B (en) 1978-07-10
DE2420706A1 (en) 1975-10-30
LU72375A1 (en) 1977-02-03
GB1478082A (en) 1977-06-29
ZA752717B (en) 1976-03-31
ATA325475A (en) 1977-11-15
EG12734A (en) 1979-06-30
JPS50145518A (en) 1975-11-21
IE41024L (en) 1975-10-29
ES436866A1 (en) 1977-01-01
NL7504853A (en) 1975-10-31

Similar Documents

Publication Publication Date Title
FI860015A (en) Method for the preparation of a vaccine against diseases caused by bacteria infecting mammalian tissues carrying piluses
AT327390B (en) PROCESS FOR THE MANUFACTURING OF SOLID, SLOW RELEASE OF THE ACTIVE INGREDIENT, PHARMACEUTICAL PREPARATIONS
ES398962A1 (en) Enzyme composition and process for the manufacture thereof
ES336810A1 (en) Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains
ES379641A1 (en) Ethylethyleneimine as an inactivation agent
MX157054A (en) PROCEDURE FOR PREPARING DERIVATIVES OF DISENZOXAZEPINE
IE41024B1 (en) Process for obtaining antigens from schistosomes, agent containing these antigens and its use
IT1064505B (en) UNIVERSAL BLOOD SEPARATION PLASTIC BAG FOR STERILE BLOOD SERUM PREPARATION FOR SINGLE USE
SE408412B (en) PROCEDURE FOR PREPARING L-3- (3,4-DIHYDROXY-PHENYL) -2-METHYL-ALANINE PEPTIDES WITH BLOOD PRESSURE-LOWING PROPERTIES
Klein The mechanism of the virucidal action of ascorbic acid
Seidel The life cycle in vitro of Hymenolepis microstoma (Cestoda)
FI99114B (en) Procedure for isolating vitreous proteins from human and animal tissue
ATE4637T1 (en) PENTADECAPEPTIDE, PROCESS FOR ITS PREPARATION AND IMMUNSIFYING AGENT.
AT352883B (en) PROCESS FOR THE PRODUCTION OF A PHARMACEUTICAL ACTIVE AMORPHIC STERYL-BETA-D-GLUCOSIDE-ESTER OR. OF THESE PREPARATIONS INCLUDED
ES387885A1 (en) Pharmaceutical preparations comprising chondroitin sulphates a and c
SU813844A1 (en) Composition for low-temperature preservtion of leukocytes
Melendez et al. Multiplication of foot and mouth disease virus in adult kidney, and embryonic lung and heart bovine tissue cultures
ATE2429T1 (en) 6-IMIDAZOLE-1-YL-3-HYDRAZINO-PYRIDAZINE, PROCESS FOR THEIR PREPARATION AND MEDICATIONS CONTAINING THEM.
GB806950A (en) Production of pharmaceutical preparations
Osuna-Carrillo et al. The in vitro cultivation of Taenia pisiformis to sexually mature adults
SU512761A1 (en) Surgical instrument for ultrasonic separation of biological tissues
AT342761B (en) PROCESS FOR THE PREPARATION OF HOMOPYRIMIDAZOLE DERIVATIVES CONTAINING STABLE PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION
Toro-Goyco et al. Schistosome ova: Rapid separation from mouse tissue by digestion with pinguinain
DAVIS et al. Intravenous use of vitamin K1 oxide
ATE12649T1 (en) OPTICALLY ACTIVE DIPEPTIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.